Julie Dobson - Safeguard Scientifics Independent Director
| SFEDelisted Stock | USD 0.46 0.19 29.23% |
Director
Ms. Julie A. Dobson is Independent Director of Safeguard Scientifics, Inc. She served as Chief Operating Officer, Telecorp PCS, Inc., a wirelessmobile phone company that was acquired by ATT Wireless, Inc. . Various executive positions during her 18year career with Bell Atlantic Corporationrationration, including President, Bell Atlantic Corporationrationrations New YorkNew Jersey Metro Region mobile phone operations, Vice President of Bell Atlantic Enterprises Corporationrationration, and President and Chief Executive Officer of Bell Atlantic Business Systems International. since 2003.
| Age | 60 |
| Tenure | 21 years |
| Phone | 610-293-0600 |
| Web | https://www.safeguard.com |
Safeguard Scientifics Management Efficiency
The company has Return on Asset of (0.0778) % which means that on every $100 spent on assets, it lost $0.0778. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2938) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics' management efficiency ratios could be used to measure how well Safeguard Scientifics manages its routine affairs as well as how well it operates its assets and liabilities.The company has 1.68 M in debt with debt to equity (D/E) ratio of 0.04, which may show that the company is not taking advantage of profits from borrowing. Safeguard Scientifics has a current ratio of 18.08, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Safeguard Scientifics until it has trouble settling it off, either with new capital or with free cash flow. So, Safeguard Scientifics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Safeguard Scientifics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Safeguard to invest in growth at high rates of return. When we think about Safeguard Scientifics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Franco Novelli | Azimut Holding SpA | 58 | |
| Jay Inglis | Central Securities | 84 | |
| Stefano Palmstein | Azimut Holding SpA | 48 | |
| Judith Stockdale | Nuveen New Jersey | 73 | |
| Radford Small | Mount Logan Capital | N/A | |
| David Shaw | Fiera Capital | 63 | |
| Monica Nani | Azimut Holding SpA | 44 | |
| Lise Pistono | Fiera Capital | N/A | |
| Teresa Nicolini | Azimut Holding SpA | 65 | |
| Christian Zugel | Central Europe Russia | 59 | |
| Marzio Zocca | Azimut Holding SpA | 56 | |
| Conrad Ciccotello | Tortoise Mlp Closed | 60 | |
| John Fielding | Flow Capital Corp | 56 | |
| Charles Heath | Tortoise Mlp Closed | 75 | |
| Albin Moschner | Nuveen New Jersey | 68 | |
| Richard Burt | European Equity Closed | 73 | |
| Colleen McMorrow | Flow Capital Corp | N/A | |
| David Gluskin | Mount Logan Capital | N/A | |
| Robert Bremner | Nuveen New Jersey | 74 | |
| Nisha Kumar | Western Asset High | 50 | |
| Gordon McMillan | Flow Capital Corp | 45 | |
Management Performance
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0778 |
Safeguard Scientifics Leadership Team
Elected by the shareholders, the Safeguard Scientifics' board of directors comprises two types of representatives: Safeguard Scientifics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safeguard. The board's role is to monitor Safeguard Scientifics' management team and ensure that shareholders' interests are well served. Safeguard Scientifics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safeguard Scientifics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julie Dobson, Independent Director | ||
| Ira Lubert, Independent Director | ||
| Russell Glass, Independent Director | ||
| Matthew Barnard, Secretary Counsel | ||
| Mark Herndon, Chief Financial Officer, Senior Vice President | ||
| Mark Dow, CFO CEO | ||
| David Kille, CFO | ||
| Alex Fuiks, Associate | ||
| Maureen Morrison, Independent Director | ||
| Albert II, Sr. VP and Managing Director of Healthcare | ||
| Scott Snyder, Senior Vice President Managing Director, Chief Technology and Innovation Officer | ||
| George MacKenzie, Independent Director | ||
| Jack Messman, Independent Director | ||
| John Shave, Vice President - Business Development and Corporate Communications | ||
| Eric Salzman, Chief Restructuring Officer | ||
| Stephen Zarrilli, President CEO, Director | ||
| Jeffrey McGroarty, CFO, Senior Vice President - Finance | ||
| Mark CPA, VP CFO | ||
| John Roberts, Independent Director | ||
| Robert Rosenthal, Executive Chairman of the Board, Principal Executive Officer | ||
| Stephen Fisher, Independent Director | ||
| Andrew Lietz, Independent Chairman of the Board | ||
| Seth Zuckerman, Associate Healthcare | ||
| Brian Sisko, Executive Vice President Managing Director | ||
| Mara Aspinall, Director | ||
| Joseph Manko, Independent Director |
Safeguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safeguard Scientifics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0778 | |||
| Current Valuation | (4.6 M) | |||
| Shares Outstanding | 16.58 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 45.02 % | |||
| Number Of Shares Shorted | 208.05 K | |||
| Price To Earning | 23.06 X | |||
| Price To Book | 0.41 X | |||
| EBITDA | (7.36 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Safeguard Scientifics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Safeguard Scientifics' short interest history, or implied volatility extrapolated from Safeguard Scientifics options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Safeguard Stock
If you are still planning to invest in Safeguard Scientifics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Safeguard Scientifics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |